Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Eph receptor tyrosine kinases are involved in various human cancers.
• EphB4 is highly expressed in head and neck squamous cell carcinoma (HNSCC), promoting tumor growth and invasion.

Purpose of the Study:

• To investigate if targeting the EphB4 receptor can improve the effectiveness of radiation therapy in HNSCC.
• To evaluate EphB4 as a potential radiosensitizer for HNSCC treatment.

Main Methods:

• Assessed EphB4 expression in HNSCC cell lines and patient-derived xenografts (PDX).
• Utilized EphB4 knockdown and sEphB4-HSA (EphB4 ligand-blocking protein) in combination with radiation.
• Evaluated cell survival, cell cycle progression, DNA damage response, apoptosis, and tumor growth in preclinical models.

Main Results:

• EphB4 is expressed in HNSCC cell lines and PDX tumors.
• EphB4 knockdown reduced HNSCC cell survival.
• Combined EphB4 downregulation and radiation enhanced G2 cell cycle arrest, DNA damage response, and apoptosis.
• Treatment with sEphB4-HSA and radiation significantly reduced tumor volume and delayed regrowth in HNSCC PDX models compared to single-agent treatments.

Conclusions:

• EphB4 targeting demonstrates therapeutic potential as a radiosensitizer in HNSCC.
• Combined EphB4 inhibition and radiation therapy represent a promising strategy for treating head and neck carcinomas.